APP and Alzheimer disease: The bulk of the affected neurons in individual patients have already crossed the T1 threshold, and thus have “committed” to uninterrupted operation of the AβPP-independent iAβ generation pathway and progression of the cellular AD pathology; these neurons were completely unresponsive to the drugs.